• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免费癌症遗传易感性连锁基因检测对新加坡检测接受率的影响。

Impact of free cancer predisposition cascade genetic testing on uptake in Singapore.

作者信息

Courtney Eliza, Chok Amanda Kay-Lyn, Ting Ang Zoe Li, Shaw Tarryn, Li Shao-Tzu, Yuen Jeanette, Ngeow Joanne

机构信息

1Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610 Singapore.

2Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, 308232 Singapore.

出版信息

NPJ Genom Med. 2019 Sep 13;4:22. doi: 10.1038/s41525-019-0096-5. eCollection 2019.

DOI:10.1038/s41525-019-0096-5
PMID:31531230
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6744424/
Abstract

Cascade testing for cancer predisposition offers a highly efficient and cost-effective method for identifying individuals at increased risk for cancer, in whom targeted interventions can often improve survival. The aim of this study was to determine the impact of free cascade testing on uptake and identify other associated factors. Demographic and clinical data were gathered prospectively for 183 probands found to have a pathogenic variant associated with cancer predisposition and their 826 first-degree relatives (FDRs). The provision of free cascade testing was significantly associated with uptake (21.6% vs 6.1%; ,   0.001). Relationship type between FDR and proband and FDR age also demonstrated significant associations, suggesting greater engagement amongst younger generations. Overall, 29.0% (53/183) of families had at least 1 FDR who underwent cascade testing. Of these families, 67.9% (36/53) had an uptake rate of at least 40.0%. Cost is a significant barrier to cascade testing uptake in Singapore. Tailored interventions targeting underrepresented groups and genetic counseling approaches supporting family communication and decision-making are necessary.

摘要

癌症易感性的级联检测为识别癌症风险增加的个体提供了一种高效且具成本效益的方法,对于这些个体,针对性干预往往可提高生存率。本研究的目的是确定免费级联检测对接受率的影响,并识别其他相关因素。前瞻性收集了183名被发现携带与癌症易感性相关的致病变异的先证者及其826名一级亲属(FDR)的人口统计学和临床数据。提供免费级联检测与接受率显著相关(21.6%对6.1%;P<0.001)。FDR与先证者之间的关系类型以及FDR年龄也显示出显著关联,表明年轻一代参与度更高。总体而言,29.0%(53/183)的家庭至少有1名FDR接受了级联检测。在这些家庭中,67.9%(36/53)的接受率至少为40.0%。成本是新加坡级联检测接受率的一个重大障碍。针对代表性不足群体的定制干预措施以及支持家庭沟通和决策的遗传咨询方法是必要的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f588/6744424/d38a75366ee6/41525_2019_96_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f588/6744424/d38a75366ee6/41525_2019_96_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f588/6744424/d38a75366ee6/41525_2019_96_Fig1_HTML.jpg

相似文献

1
Impact of free cancer predisposition cascade genetic testing on uptake in Singapore.免费癌症遗传易感性连锁基因检测对新加坡检测接受率的影响。
NPJ Genom Med. 2019 Sep 13;4:22. doi: 10.1038/s41525-019-0096-5. eCollection 2019.
2
Predictive Testing for Tumor Predisposition Syndromes in Pediatric Relatives: An Asian Experience.儿科亲属肿瘤易感性综合征的预测性检测:亚洲经验
Front Pediatr. 2020 Oct 30;8:568528. doi: 10.3389/fped.2020.568528. eCollection 2020.
3
Cascade testing for hereditary cancer in Singapore: how population genomics help guide clinical policy.新加坡遗传性癌症的级联检测:人群基因组学如何指导临床决策。
Fam Cancer. 2024 Jun;23(2):133-140. doi: 10.1007/s10689-024-00376-1. Epub 2024 Apr 25.
4
A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.特立尼达和多巴哥乳腺癌女性及其家族的临床结构化和合作式基因检测方法。
Breast Cancer Res Treat. 2019 Apr;174(2):469-477. doi: 10.1007/s10549-018-5045-y. Epub 2018 Dec 4.
5
Innovative Implementation Strategies for Familial Hypercholesterolemia Cascade Testing: The Impact of Genetic Counseling.家族性高胆固醇血症级联检测的创新实施策略:遗传咨询的影响
J Pers Med. 2024 Aug 9;14(8):841. doi: 10.3390/jpm14080841.
6
Use of a chatbot to increase uptake of cascade genetic testing.利用聊天机器人提高级联基因检测的利用率。
J Genet Couns. 2022 Oct;31(5):1219-1230. doi: 10.1002/jgc4.1592. Epub 2022 May 26.
7
Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review.级联遗传咨询和检测在遗传性综合征中的应用:以遗传性心血管疾病为模型:一篇叙述性综述。
Fam Cancer. 2024 Jun;23(2):155-164. doi: 10.1007/s10689-023-00356-x. Epub 2024 Jan 6.
8
Cascade testing for inherited arrhythmia conditions: Experiences and attitudes of family communication approaches for a Canadian cohort.级联检测遗传性心律失常疾病:加拿大队列的家族沟通方法的经验和态度。
J Genet Couns. 2022 Jun;31(3):815-828. doi: 10.1002/jgc4.1550. Epub 2022 Jan 14.
9
The Impact of Proband Indication for Genetic Testing on the Uptake of Cascade Testing Among Relatives.先证者基因检测指征对亲属级联检测接受度的影响。
Front Genet. 2022 Jun 16;13:867226. doi: 10.3389/fgene.2022.867226. eCollection 2022.
10
Proband family uptake of familial-genetic counselling.先证者家系对家族遗传咨询的接受情况。
Psychooncology. 2000 Nov-Dec;9(6):522-7. doi: 10.1002/1099-1611(200011/12)9:6<522::aid-pon492>3.0.co;2-s.

引用本文的文献

1
Healthcare provider-mediated cascade testing of Lynch syndrome to at-risk family members: an interview study.医疗服务提供者介导的林奇综合征高危家庭成员级联检测:一项访谈研究
Fam Cancer. 2025 Feb 26;24(1):25. doi: 10.1007/s10689-025-00450-2.
2
Patients' perspectives regarding health professionals contacting their relatives about genetic risk directly (with patient consent).患者对于医疗专业人员在获得患者同意后直接联系其亲属告知遗传风险的看法。
Eur J Hum Genet. 2025 Apr;33(4):485-495. doi: 10.1038/s41431-024-01764-y. Epub 2024 Dec 17.
3
BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing.

本文引用的文献

1
Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative.对遗传性癌症风险的亲属进行级联遗传检测:在线倡议的结果。
J Natl Cancer Inst. 2019 Jan 1;111(1):95-98. doi: 10.1093/jnci/djy147.
2
Predictors of next-generation sequencing panel selection using a shared decision-making approach.采用共同决策方法选择下一代测序面板的预测因素。
NPJ Genom Med. 2018 Apr 27;3:11. doi: 10.1038/s41525-018-0050-y. eCollection 2018.
3
Delivery Of Cascade Screening For Hereditary Conditions: A Scoping Review Of The Literature.
BRCA 突变型乳腺癌:基因检测的未满足需求、挑战和治疗获益。
Br J Cancer. 2024 Nov;131(9):1400-1414. doi: 10.1038/s41416-024-02827-z. Epub 2024 Aug 30.
4
International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents.儿童和青少年嗜铬细胞瘤和副神经节瘤的诊断和管理国际共识声明。
Nat Rev Endocrinol. 2024 Dec;20(12):729-748. doi: 10.1038/s41574-024-01024-5. Epub 2024 Aug 15.
5
Familial communication and cascade testing following elective genomic testing.选择性基因检测后的家族沟通与级联检测
J Genet Couns. 2025 Feb;34(1):e1907. doi: 10.1002/jgc4.1907. Epub 2024 May 16.
6
Cascade testing for hereditary cancer in Singapore: how population genomics help guide clinical policy.新加坡遗传性癌症的级联检测:人群基因组学如何指导临床决策。
Fam Cancer. 2024 Jun;23(2):133-140. doi: 10.1007/s10689-024-00376-1. Epub 2024 Apr 25.
7
Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review.改善遗传性癌症综合征级联检测实施情况的策略:一项系统综述
NPJ Genom Med. 2024 Apr 3;9(1):26. doi: 10.1038/s41525-024-00412-0.
8
Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs.级联遗传检测在遗传性癌症综合征中的应用:障碍与突破的综述。
Fam Cancer. 2024 Jun;23(2):111-120. doi: 10.1007/s10689-024-00373-4. Epub 2024 Mar 26.
9
Privacy Implications of Contacting the At-Risk Relatives of Patients with Medically Actionable Genetic Predisposition, with Patient Consent: A Hypothetical Australian Case Study.经患者同意后联系具有医学可干预遗传易感性患者的高危亲属所涉及的隐私问题:一项澳大利亚的假设性案例研究
BioTech (Basel). 2023 Jun 2;12(2):45. doi: 10.3390/biotech12020045.
10
Direct notification by health professionals of relatives at-risk of genetic conditions (with patient consent): views of the Australian public.卫生专业人员直接通知有遗传疾病风险的亲属(经患者同意):澳大利亚公众的看法。
Eur J Hum Genet. 2024 Jan;32(1):98-108. doi: 10.1038/s41431-023-01395-9. Epub 2023 Jun 6.
遗传性疾病级联筛查的实施:文献综述
Health Aff (Millwood). 2018 May;37(5):801-808. doi: 10.1377/hlthaff.2017.1630.
4
Pathogenic Germline Variants in 10,389 Adult Cancers.10389 例成年癌症中的致病变异体种系变异。
Cell. 2018 Apr 5;173(2):355-370.e14. doi: 10.1016/j.cell.2018.03.039.
5
Familial communication and cascade testing among relatives of BRCA population screening participants.BRCA 人群筛查参与者亲属中的家族沟通和级联检测。
Genet Med. 2018 Nov;20(11):1446-1454. doi: 10.1038/gim.2018.26. Epub 2018 Mar 29.
6
Factors influencing the decision to share cancer genetic results among family members: An in-depth interview study of women in an Asian setting.影响家庭成员间分享癌症遗传结果决策的因素:亚洲背景下女性的深入访谈研究。
Psychooncology. 2018 Mar;27(3):998-1004. doi: 10.1002/pon.4627. Epub 2018 Jan 24.
7
Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers.BRCA 种系检测在乳腺癌女性患者中的成本效益分析,以及突变携带者家族成员的级联检测。
Genet Med. 2018 Sep;20(9):985-994. doi: 10.1038/gim.2017.231. Epub 2018 Jan 4.
8
Uptake of genetic testing by the children of Lynch syndrome variant carriers across three generations.三代林奇综合征变异携带者子女的基因检测接受情况。
Eur J Hum Genet. 2017 Nov;25(11):1237-1245. doi: 10.1038/ejhg.2017.132. Epub 2017 Aug 23.
9
Quantifying family dissemination and identifying barriers to communication of risk information in Australian BRCA families.量化澳大利亚 BRCA 家族中的家族传播,并确定风险信息沟通障碍。
Genet Med. 2017 Dec;19(12):1323-1331. doi: 10.1038/gim.2017.52. Epub 2017 May 11.
10
A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.英国卵巢癌女性中胚系BRCA1和BRCA2检测的成本效益评估。
Value Health. 2017 Apr;20(4):567-576. doi: 10.1016/j.jval.2017.01.004. Epub 2017 Mar 3.